HEADER OXIDOREDUCTASE 27-JUN-18 6GXY TITLE TRYPAREDOXIN FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH CFT COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRYPAREDOXIN; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: TRYX; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRYPANOSOMA BRUCEI BRUCEI; SOURCE 3 ORGANISM_TAXID: 5702; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COVALENT INHIBITOR, PHOTOREDUCTION, INHIBITOR-INDUCED DIMERIZATION, KEYWDS 2 MONOMER-DIMER MIXTURE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR N.BADER,A.WAGNER,U.HELLMICH,H.SCHINDELIN REVDAT 3 17-JAN-24 6GXY 1 REMARK REVDAT 2 13-MAR-19 6GXY 1 JRNL REVDAT 1 16-JAN-19 6GXY 0 JRNL AUTH A.WAGNER,T.A.LE,M.BRENNICH,P.KLEIN,N.BADER,E.DIEHL,D.PASZEK, JRNL AUTH 2 A.K.WEICKHMANN,N.DIRDJAJA,R.L.KRAUTH-SIEGEL,B.ENGELS, JRNL AUTH 3 T.OPATZ,H.SCHINDELIN,U.A.HELLMICH JRNL TITL INHIBITOR-INDUCED DIMERIZATION OF AN ESSENTIAL JRNL TITL 2 OXIDOREDUCTASE FROM AFRICAN TRYPANOSOMES. JRNL REF ANGEW. CHEM. INT. ED. ENGL. V. 58 3640 2019 JRNL REFN ESSN 1521-3773 JRNL PMID 30605929 JRNL DOI 10.1002/ANIE.201810470 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 30805 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.168 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1564 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2125 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.2940 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3392 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 624 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.51000 REMARK 3 B22 (A**2) : 0.09000 REMARK 3 B33 (A**2) : 0.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.66000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.174 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.147 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3844 ; 0.009 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): 3419 ; 0.000 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5286 ; 1.375 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7983 ; 3.745 ; 3.002 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 496 ; 6.417 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 159 ;36.931 ;24.088 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 585 ;12.234 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;12.443 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 556 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4418 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 826 ; 0.007 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1895 ; 1.325 ; 3.626 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1894 ; 1.323 ; 3.625 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2410 ; 2.108 ; 8.124 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2411 ; 2.109 ; 8.125 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1949 ; 1.596 ; 3.934 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1950 ; 1.596 ; 3.935 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2873 ; 2.487 ; 8.662 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 4912 ; 5.980 ;24.958 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 4695 ; 5.633 ;23.467 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6GXY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-JUN-18. REMARK 100 THE DEPOSITION ID IS D_1200010707. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.980004 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32420 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.14100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.62400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1O73 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.87 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.045 M NA-CITRATE, 0.1 M NA-ACETATE, REMARK 280 PH 5.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.00450 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU B 133 N CA C O CB CG CD REMARK 480 GLU B 133 OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 86 -154.17 -98.07 REMARK 500 TRP A 142 61.51 62.50 REMARK 500 THR B 12 -61.83 -120.77 REMARK 500 TRP B 86 -144.41 -115.93 REMARK 500 TRP C 86 -153.14 -108.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 496 DISTANCE = 7.30 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FFN A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FFN C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FFN B 201 and CYS B REMARK 800 40 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6GXG RELATED DB: PDB REMARK 900 IN 6GXG ALL COVALENT BONDS BETWEEN THE INHIBITOR AND THE PROTEIN REMARK 900 HAVE BEEN BROKEN BY THE X-RAY BEAM. IN THIS ENTRY TWO PROTEIN- REMARK 900 INHIBITOR COMPLEXES (A AND B CHAIN) FEATURE A MIXTURE OF REMARK 900 COLVALENTLY BONDED AND NON-BONDED INHIBITORS WHILE THE C-CHAIN ONLY REMARK 900 CONTAINS A NON-COVALENTLY BOUND INHIBITOR. DBREF 6GXY A 2 144 UNP O77404 TYPX_TRYBB 2 144 DBREF 6GXY B 2 144 UNP O77404 TYPX_TRYBB 2 144 DBREF 6GXY C 2 144 UNP O77404 TYPX_TRYBB 2 144 SEQADV 6GXY GLY A -1 UNP O77404 EXPRESSION TAG SEQADV 6GXY MET A 0 UNP O77404 EXPRESSION TAG SEQADV 6GXY GLY A 1 UNP O77404 EXPRESSION TAG SEQADV 6GXY GLY B -1 UNP O77404 EXPRESSION TAG SEQADV 6GXY MET B 0 UNP O77404 EXPRESSION TAG SEQADV 6GXY GLY B 1 UNP O77404 EXPRESSION TAG SEQADV 6GXY GLY C -1 UNP O77404 EXPRESSION TAG SEQADV 6GXY MET C 0 UNP O77404 EXPRESSION TAG SEQADV 6GXY GLY C 1 UNP O77404 EXPRESSION TAG SEQRES 1 A 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA SEQRES 2 A 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY SEQRES 3 A 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA SEQRES 4 A 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU SEQRES 5 A 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE SEQRES 6 A 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP SEQRES 7 A 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU SEQRES 8 A 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS SEQRES 9 A 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE SEQRES 10 A 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG SEQRES 11 A 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO SEQRES 12 A 146 TRP PRO ASN SEQRES 1 B 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA SEQRES 2 B 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY SEQRES 3 B 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA SEQRES 4 B 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU SEQRES 5 B 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE SEQRES 6 B 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP SEQRES 7 B 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU SEQRES 8 B 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS SEQRES 9 B 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE SEQRES 10 B 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG SEQRES 11 B 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO SEQRES 12 B 146 TRP PRO ASN SEQRES 1 C 146 GLY MET GLY SER GLY LEU ALA LYS TYR LEU PRO GLY ALA SEQRES 2 C 146 THR ASN LEU LEU SER LYS SER GLY GLU VAL SER LEU GLY SEQRES 3 C 146 SER LEU VAL GLY LYS THR VAL PHE LEU TYR PHE SER ALA SEQRES 4 C 146 SER TRP CYS PRO PRO CYS ARG GLY PHE THR PRO VAL LEU SEQRES 5 C 146 ALA GLU PHE TYR GLU LYS HIS HIS VAL ALA LYS ASN PHE SEQRES 6 C 146 GLU VAL VAL LEU ILE SER TRP ASP GLU ASN GLU SER ASP SEQRES 7 C 146 PHE HIS ASP TYR TYR GLY LYS MET PRO TRP LEU ALA LEU SEQRES 8 C 146 PRO PHE ASP GLN ARG SER THR VAL SER GLU LEU GLY LYS SEQRES 9 C 146 THR PHE GLY VAL GLU SER ILE PRO THR LEU ILE THR ILE SEQRES 10 C 146 ASN ALA ASP THR GLY ALA ILE ILE GLY THR GLN ALA ARG SEQRES 11 C 146 THR ARG VAL ILE GLU ASP PRO ASP GLY ALA ASN PHE PRO SEQRES 12 C 146 TRP PRO ASN HET FFN A 201 18 HET FFN B 201 18 HET FFN C 201 18 HETNAM FFN 5-(4-FLUOROPHENYL)-2-METHYL-3~{H}-THIENO[2,3- HETNAM 2 FFN D]PYRIMIDIN-4-ONE FORMUL 4 FFN 3(C13 H9 F N2 O S) FORMUL 7 HOH *624(H2 O) HELIX 1 AA1 GLY A 3 LEU A 8 1 6 HELIX 2 AA2 GLY A 24 VAL A 27 5 4 HELIX 3 AA3 CYS A 40 HIS A 58 1 19 HELIX 4 AA4 ASN A 73 GLY A 82 1 10 HELIX 5 AA5 PRO A 90 SER A 95 5 6 HELIX 6 AA6 THR A 96 PHE A 104 1 9 HELIX 7 AA7 GLN A 126 ASP A 134 1 9 HELIX 8 AA8 SER B 2 TYR B 7 5 6 HELIX 9 AA9 GLY B 24 VAL B 27 5 4 HELIX 10 AB1 CYS B 40 HIS B 58 1 19 HELIX 11 AB2 ASN B 73 LYS B 83 1 11 HELIX 12 AB3 PRO B 90 SER B 95 5 6 HELIX 13 AB4 THR B 96 GLY B 105 1 10 HELIX 14 AB5 GLN B 126 ASP B 134 1 9 HELIX 15 AB6 SER C 2 TYR C 7 5 6 HELIX 16 AB7 GLY C 24 VAL C 27 5 4 HELIX 17 AB8 CYS C 40 HIS C 58 1 19 HELIX 18 AB9 ASN C 73 LYS C 83 1 11 HELIX 19 AC1 GLN C 93 PHE C 104 1 12 HELIX 20 AC2 GLN C 126 ASP C 134 1 9 SHEET 1 AA1 2 ASN A 13 LEU A 14 0 SHEET 2 AA1 2 VAL A 21 SER A 22 -1 O VAL A 21 N LEU A 14 SHEET 1 AA2 5 LEU A 87 ALA A 88 0 SHEET 2 AA2 5 PHE A 63 SER A 69 1 N VAL A 65 O LEU A 87 SHEET 3 AA2 5 THR A 30 SER A 36 1 N TYR A 34 O VAL A 66 SHEET 4 AA2 5 THR A 111 ASN A 116 -1 O ILE A 115 N VAL A 31 SHEET 5 AA2 5 ILE A 122 GLY A 124 -1 O ILE A 123 N THR A 114 SHEET 1 AA3 2 ASN B 13 SER B 16 0 SHEET 2 AA3 2 GLY B 19 SER B 22 -1 O VAL B 21 N LEU B 14 SHEET 1 AA4 5 LEU B 87 ALA B 88 0 SHEET 2 AA4 5 PHE B 63 SER B 69 1 N LEU B 67 O LEU B 87 SHEET 3 AA4 5 THR B 30 SER B 36 1 N TYR B 34 O ILE B 68 SHEET 4 AA4 5 THR B 111 ASN B 116 -1 O ILE B 115 N VAL B 31 SHEET 5 AA4 5 ILE B 122 GLY B 124 -1 O GLY B 124 N THR B 114 SHEET 1 AA5 2 ASN C 13 LEU C 15 0 SHEET 2 AA5 2 GLU C 20 SER C 22 -1 O VAL C 21 N LEU C 14 SHEET 1 AA6 5 LEU C 87 ALA C 88 0 SHEET 2 AA6 5 PHE C 63 SER C 69 1 N LEU C 67 O LEU C 87 SHEET 3 AA6 5 THR C 30 SER C 36 1 N TYR C 34 O VAL C 66 SHEET 4 AA6 5 THR C 111 ASN C 116 -1 O ILE C 113 N LEU C 33 SHEET 5 AA6 5 ILE C 122 GLY C 124 -1 O GLY C 124 N THR C 114 LINK SG ACYS A 40 C01 FFN A 201 1555 1555 1.98 LINK SG ACYS B 40 C01 FFN B 201 1555 1555 1.96 CISPEP 1 ILE A 109 PRO A 110 0 -0.94 CISPEP 2 PHE A 140 PRO A 141 0 2.26 CISPEP 3 ILE B 109 PRO B 110 0 -3.77 CISPEP 4 PHE B 140 PRO B 141 0 3.16 CISPEP 5 ILE C 109 PRO C 110 0 1.35 CISPEP 6 PHE C 140 PRO C 141 0 6.39 SITE 1 AC1 11 TRP A 39 CYS A 40 TRP A 70 VAL A 106 SITE 2 AC1 11 GLU A 107 SER A 108 ILE A 109 HOH A 314 SITE 3 AC1 11 TRP B 39 FFN B 201 HOH B 484 SITE 1 AC2 14 GLU A 52 LYS A 56 PRO A 135 ASP A 136 SITE 2 AC2 14 HOH A 357 HOH A 361 HOH A 369 HOH A 398 SITE 3 AC2 14 TRP C 39 CYS C 40 PRO C 41 ILE C 109 SITE 4 AC2 14 HOH C 348 HOH C 442 SITE 1 AC3 15 TRP A 39 FFN A 201 ALA B 37 SER B 38 SITE 2 AC3 15 TRP B 39 PRO B 41 PRO B 42 CYS B 43 SITE 3 AC3 15 ARG B 44 TRP B 70 VAL B 106 GLU B 107 SITE 4 AC3 15 SER B 108 ILE B 109 HOH B 391 CRYST1 39.630 96.009 48.276 90.00 96.57 90.00 P 1 21 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025233 0.000000 0.002904 0.00000 SCALE2 0.000000 0.010416 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020851 0.00000